These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33234745)

  • 21. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
    Chan AC; Poon RT; Cheung TT; Chok KS; Chan SC; Fan ST; Lo CM
    World J Surg; 2012 Jan; 36(1):151-6. PubMed ID: 22030561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.
    Wang Y; Liao Y; Liu W; Zhang Y; Yuan Y; Qiu Y; Qiu J; Yang Z; He W; Wang C; Li K; Shi Y; Zuo D; Yuan Y; Li B
    Dig Surg; 2021; 38(1):46-57. PubMed ID: 33152739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
    AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.
    Wakayama K; Kamiyama T; Yokoo H; Kakisaka T; Kamachi H; Tsuruga Y; Nakanishi K; Shimamura T; Todo S; Taketomi A
    World J Surg Oncol; 2013 Oct; 11():259. PubMed ID: 24093164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
    Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
    Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma.
    Takeishi K; Maeda T; Tsujita E; Yamashita Y; Harada N; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Shirabe K; Maehara Y
    Anticancer Res; 2015 May; 35(5):3061-6. PubMed ID: 25964596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Int J Surg; 2017 Oct; 46():178-185. PubMed ID: 28890407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R
    PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
    Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
    Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis.
    Hu Z; Huang P; Zhou Z; Li W; Xu J; Xu K; Wang J; Zhang H
    Clin Transl Oncol; 2018 Jun; 20(6):729-739. PubMed ID: 29110217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection.
    Saito R; Amemiya H; Hosomura N; Kawaida H; Maruyama S; Shimizu H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2019 Jun; 39(6):3033-3038. PubMed ID: 31177145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Resection for Intrahepatic Cholangiocarcinoma-Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period.
    Lang H; Baumgart J; Heinrich S; Huber T; Heuft LK; Margies R; Mittler J; Hahn F; Gerber TS; Foerster F; Weinmann A; Marquardt JU; Kloeckner R; Straub BK; Bartsch F
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.
    Lee KF; Chong CCN; Fong AKW; Fung AKY; Lok HT; Cheung YS; Wong J; Lai PBS
    Hepatobiliary Surg Nutr; 2018 Oct; 7(5):320-330. PubMed ID: 30498708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection.
    Kim HS; Yi NJ; Kim JM; Joh JW; Lee KW; Suh KS
    Ann Surg Treat Res; 2021 Aug; 101(2):85-92. PubMed ID: 34386457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.